Mostly Markets
Subscribe
Stocks/Health Care/Health Care Equipment

SterisSTE

Health Care Equipment · Dublin, Ireland · In the S&P 500
Solid business
$227.12−2.16%After hours: $227.12 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 4.1% over 1 year
Steris over 1 yearDaily close, $, to 30 Oct 2026
$200$220$240$260Nov2026MarMayJulSep$227.12$200$250NovMarJul$227.12
Source: Nasdaq daily closes
Market value$22.14B
Price to earnings27.7x
Forward P/E19.8x
Dividend yield1.22%
Year to date−10.4%
One year−4.1%
Next earningsWed 4 Nov, after the close
SectorHealth Care
52-week range (closes)
$199.40$268.65

Quality and valuation

How Steris compares with other health care stocks. A description, not a recommendation.

Steris and 7 health care equipment peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: in line with its sector

An average business among health care companies, priced about in line with them.

Steris trades at 19.8 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +8.4% vs +7.8%
  • Keeps less of each sale (gross margin): 44.4% vs 65.3%
  • More profitable (operating margin): 18.9% vs 13.3%
  • Turns less of its sales into cash: 15.3% vs 15.9%
STE trades at 19.8x forward earnings, above the sector medianForward p/e, Health Care Equipment peers
BSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xSTE19.8xEW29.3xISRG37.5xSector median 19.1xBSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xSTE19.8xEW29.3xISRG37.5xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 27.8x earnings, STE is cheaper than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
40x50x60xAverage 39.7x2025202627.8x40x60xAverage 39.7x2025202627.8x
Source: Nasdaq prices; SEC filings

Financials

From Steris's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 7.3% from a year earlierQuarterly revenue, $bn, latest Q1 ’27
$0.0bn$0.5bn$1.0bn$1.5bnQ2 ’25Q4 ’25Q2 ’26$1.5bnQ1 ’27$0bn$1bnQ2 ’25Q4 ’25Q2 ’26$1.5bnQ1 ’27
Source: SEC filings
Growth sped up to +7.3% last quarterRevenue growth, year on year, %
0%2%5%8%Q2 ’25Q4 ’25Q2 ’267.3%Q1 ’270%5%Q2 ’25Q4 ’25Q2 ’267.3%Q1 ’27
Source: SEC filings
Operating margin was 19.1% last quarterOperating income as a share of revenue, %
0%5%10%15%Q2 ’25Q4 ’25Q2 ’2619.1%Q1 ’270%10%Q2 ’25Q4 ’25Q2 ’2619.1%Q1 ’27
Source: SEC filings
Free cash flow was $926 million over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
$0m$100m$200m$300mQ2 ’25Q4 ’25Q2 ’26$280mQ1 ’27$0m$200mQ2 ’25Q4 ’25Q2 ’26$280mQ1 ’27
Source: SEC filings
Last 12 monthsSTESector median
Revenue growth+8.4%+7.8%
Gross margin44.4%65.3%
Operating margin18.9%13.3%
Free cash flow margin15.3%15.9%
Price to earnings27.7x30.2x

Stories on Steris

We haven't written about Steris yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Equipment, by market value.

CompanyPriceTodayYTDValue
ABTAbbott Laboratories$106.20+1.56%−15.2%$184B
ISRGIntuitive Surgical$432.01−3.73%−23.7%$150B
MDTMedtronic$96.54−0.59%+0.5%$123B
SYKStryker$291.86−6.38%−17.0%$112B
BSXBoston Scientific$41.98−1.66%−56.0%$60.84B
BDXBecton Dickinson$197.88−0.23%+27.4%$53.90B
EWEdwards Lifesciences$92.01−2.57%+7.9%$53.03B
IDXXIdexx Laboratories$551.21−4.30%−18.5%$43.42B